Can Robaxin (Methocarbamol) cause hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hypotension Risk with Robaxin (Methocarbamol)

Robaxin (Methocarbamol) can cause hypotension, as evidenced by its cardiovascular effects which include bradycardia and hypotension 1.

  • The precise mechanism of action of Methocarbamol is unclear, but its adverse effects profile indicates a potential risk for hypotension.
  • Drowsiness and dizziness are also among the adverse effects, suggesting that Methocarbamol may have a broader impact on the cardiovascular system and overall patient stability 1.
  • While the exact dosage and treatment duration that increase the risk of hypotension are not specified in the provided evidence, it is crucial for clinicians to be aware of this potential side effect, especially in patients with pre-existing cardiovascular conditions.
  • The elimination of Methocarbamol is significantly impaired in certain conditions, which could potentially lead to increased levels of the drug in the body and a higher risk of adverse effects, including hypotension 1.

From the FDA Drug Label

ADVERSE REACTIONS ... Cardiovascular system: Bradycardia, flushing, hypotension, syncope, thrombophlebitis OVERDOSAGE ... Overdose of methocarbamol ... includes the following symptoms: ... hypotension, seizures, and coma.

Yes, Robaxin (Methocarbamol) can cause hypotension, as it is listed as a potential adverse reaction in the drug label 2 and also as a symptom of overdose 2.

From the Research

Orthostatic Hypotension and Medications

The relationship between medications and orthostatic hypotension is well-documented in various studies 3, 4. Orthostatic hypotension is defined as a drop in systolic blood pressure of at least 20mmHg or a drop in diastolic blood pressure of at least 10mmHg within 3 minutes of standing 5.

Medications that Can Cause Hypotension

Several medications can cause hypotensive effects, including:

  • Diuretics and vasodilators, which are commonly used to treat hypertension 3
  • Tricyclic antidepressants, such as imipramine, which can cause orthostatic hypotension 4
  • Monoamine-oxidase inhibitors, which can cause orthostatic hypotension or hypertensive crisis due to tyramine-containing food 4
  • Serotonin-norepinephrine reuptake inhibitors, such as venlafaxine, which can increase the risk of hypertension 4
  • Dopamine-norepinephrine reuptake inhibitors, such as bupropion, which can lead to blood pressure increases or orthostatic hypotension 4

Robaxin (Methocarbamol) and Hypotension

There is no direct evidence in the provided studies that links Robaxin (Methocarbamol) to hypotension. However, it is essential to note that Robaxin is a muscle relaxant that can cause drowsiness, dizziness, and lightheadedness, which may increase the risk of falls, especially in older adults 6, 3.

Key Points

  • Orthostatic hypotension is a common disorder that can be caused by various medications and medical conditions 5, 3
  • Medications that can cause hypotensive effects should be used with caution, especially in older adults and patients with cardiovascular diseases 3, 4
  • Patients taking medications that can cause hypotension should be monitored regularly for signs and symptoms of orthostatic hypotension 6, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Orthostatic hypotension in older adults: the role of medications.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2020

Research

Antidepressant Drugs Effects on Blood Pressure.

Frontiers in cardiovascular medicine, 2021

Research

Orthostatic hypotension: evaluation and treatment.

Cardiovascular & hematological disorders drug targets, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.